Nigella Sativa COVID-19 studies.
Recent:Ali Miraz.
Submit updates/corrections .
May 31 |
(Preprint) (meta analysis) | Nigella Sativa for COVID-19: real-time meta analysis of 11 studies |
| Statistically significant improvements are seen for mortality, hospitalization, recovery, cases, and viral clearance. 8 studies from 7 independent teams in 6 different countries show statistically significant improvements in isolation (.. | ||
Mar 31 |
et al., Pakistan BioMedical Journal, doi:10.54393/pbmj.v6i3.853 | Computational Prediction of Nigella sativa Compounds as Potential Drug Agents for Targeting Spike Protein of SARS-CoV-2 |
| In Silico study identifying multiple compounds from nigella sativa as inhibitors of SARS-CoV-2. Methyl stearate showed the lowest binding energy and formed a stable complex with the spike protein. | ||
Feb 20 |
et al., International Journal of Clinical Practice, doi:10.1155/2023/9917306 | Nigelladine A among Selected Compounds from Nigella sativa Exhibits Propitious Interaction with Omicron Variant of SARS-CoV-2: An In Silico Study |
| In Silico study of 96 phytochemical compounds of nigella sativa, identifying Nigelladine A as the most promising compound for SARS-CoV-2 inhibition with the highest docking scores for the spike protein and Mpro. Dithymoquinone, kaempferol.. | ||
Nov 8 |
et al., Frontiers in Pharmacology, doi:10.3389/fphar.2022.1011522 | The effect of Nigella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial |
| 77% improved recovery [p=0.09] and 61% improved viral clearance [p=0.08]. 120 patient RCT comparing vitamin D, nigella sativa, and combined vitamin D+nigella sativa, showing improved symptom recovery and viral clearance with both vitamin D and nigella sativa, and further improvements with the combination of bot.. | ||
Sep 19 |
et al., International Journal of Environmental Research and Public Health, doi:10.3390/ijerph191811798 | The Effect of Short Treatment with Nigella Sativa on Symptoms, the Cluster of Differentiation (CD) Profile, and Inflammatory Markers in Mild COVID-19 Patients: A Randomized, Double-Blind Controlled Trial |
| RCT 262 mild cases in Saudi Arabia, showing no significant difference in outcomes. The only symptomatic outcomes provided are for individual symptoms, with large differences in the baseline frequencies. 75 patients were lost to followup w.. | ||
Jul 11 |
et al., Processes, doi:10.3390/pr10071346 (In Vitro) | Pharmacological Profile of Nigella sativa Seeds in Combating COVID-19 through In-Vitro and Molecular Docking Studies |
| In Vitro study of nigella sativa's effect on oxidative stress, hemolysis, proteolysis, and glycation, and In Silico study for SARS-CoV-2 antiviral potential, suggesting beneficial effects for COVID-19. | ||
Jul 5 |
et al., Phytotherapy Research, doi:10.1002/ptr.7531 | Efficacy of polyherbal formulations for prevention of COVID-19 infection in high-risk subjects: A randomized open-label controlled clinical trial |
| 49% fewer cases [p=0.36]. RCT 251 high-risk individuals in India, mostly with direct contact with COVID-19 positive patients, testing polyherbal formulations Infuza, which includes nigella sativa, and Kulzam. Both formulations showed lower risk, without statisical.. | ||
Jun 3 |
et al., Integrative Medicine Research, doi:10.1016/j.imr.2022.100869 | Efficacy of a Persian herbal medicine compound on coronavirus disease 2019 (COVID-19): a randomized clinical trial |
| 27% lower need for oxygen therapy [p=0.007] and 29% shorter hospitalization [p<0.0001]. Small RCT 41 patients treated with nigella sativa, glycyrrhiza glabra, punica granatum, and rheum palmatum, and 41 control patients, showing shorter hospitalization with treatment. | ||
May 7 |
et al., Pathogens, doi:10.3390/pathogens11050551 | A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of ThymoQuinone Formula (TQF) for Treating Outpatient SARS-CoV-2 |
| 9% faster improvement [p=0.78] and 43% improved viral clearance [p=0.31]. 52 patient RCT in the USA with nigella sativa component thymoquinone, showing improved recovery with treatment. There was a significantly faster decline in the total symptom burden, and a significant increase in CD8+ and helper CD4+ centr.. | ||
Apr 20 |
et al., Toxicology Reports, doi:10.1016/j.toxrep.2022.04.020 (Dosing) | A phase I clinical trial to evaluate the safety of thymoquinone -rich black cumin oil (BlaQmax®) on healthy subjects: Randomized, double-blinded, placebo-controlled prospective study |
| Phase 1 trial of high thymoquinone content (5%) black cumin oil finding treatment to be safe without any major side effects or adverse events. There was a significant reduction in total cholesterol, LDL, and triglycerides, and increased H.. | ||
Feb 28 |
et al., Tropical Journal of Pharmaceutical Research, doi:10.4314/tjpr.v21i2.13 | Immune-boosting effect of natural remedies and supplements on progress of, and recovery from COVID-19 infection |
| no change in severe cases [p=1]. Retrospective survey-based analysis of 349 COVID-19 patients, showing no significant difference with nigella sativa prophylaxis in unadjusted analysis. REC/UG/2020/03. | ||
Jan 24 |
et al., Brazilian Journal of Biology, doi:10.1590/1519-6984.25066 | Inhibitory effect of thymoquinone from Nigella sativa against SARS-CoV-2 main protease. An in-silico study |
| In Silico analysis of thymoquinone from nigella sativa showing good binding affinity with SARS-CoV-2 Mpro. | ||
Jan 1 |
et al., Bioorganic Chemistry, doi:10.1016/j.bioorg.2021.105587 (In Vitro) | In vitro Potential Antiviral SARS-CoV-19- Activity of Natural Product Thymohydroquinone and Dithymoquinone from Nigela sativia |
| In Vitro and In Silico study of nigella sativa components, showing anti-SARS-CoV-2 activity at non-cytotoxic nanomolar concentrations for thymohydroquinone with selectivity index 1.4. | ||
Dec 22 2021 |
et al., Natural Product Research, doi:10.1080/14786419.2021.2018430 | Nigellidine (Nigella sativa, black-cumin seed) docking to SARS CoV-2 nsp3 and host inflammatory proteins may inhibit viral replication/transcription |
| In Silico study showing nigella sativa docking to SARS CoV-2 Nsp3 and host inflammatory proteins, which may inhibit viral replication. | ||
Oct 13 2021 |
et al., Processes, doi:10.3390/pr9101814 | Identifying the Most Potent Dual-Targeting Compound(s) against 3CLprotease and NSP15exonuclease of SARS-CoV-2 from Nigella sativa: Virtual Screening via Physicochemical Properties, Docking and Dynamic Simulation Analysis |
| In Silico study predicting that nigella sativa component dithymoquinone has good affinity and stability against SARS-CoV-2 3CLpro and NSP15, suggesting potential benefits for COVID-19 treatment. | ||
Oct 4 2021 |
et al., Phytotherapy Research, doi:10.1002/ptr.7277 | Efficacy of Persian medicine herbal formulations (capsules and decoction) compared to standard care in patients with COVID-19, a multicenter open-labeled, randomized, controlled clinical trial |
| 61% lower ICU admission [p=0.28], 70% shorter hospitalization [p=0.001], and 67% improved recovery [p=0.001]. RCT 358 hospitalized patients in Iran, 184 receiving treatment with a combination of nigella sativa and several other herbal medicines, showing shorter hospitalization time and improved recovery with treatment. IR.TUMS.VCR.REC.1399.024. | ||
Sep 8 2021 |
et al., Saudi Journal of Biological Sciences, doi:10.1016/j.sjbs.2021.09.002 | Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach |
| In Silico study identifying phytochemicals from nigella sativa (𝛼-hederin, dithymoquinone, negillicine, and negillidine) as potential SARS-CoV-2 RNA-dependent RNA polymerase inhibitors. | ||
Aug 15 2021 |
et al., Complementary Therapies in Medicine, doi:10.1016/j.ctim.2021.102769 | Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial |
| 75% lower hospitalization [p=0.37] and 43% improved recovery [p=0.0002]. RCT 183 mild COVID-19 outpatients in Saudi Arabia, 91 treated with Nigella Sativa, showing lower hospitalization and faster recovery with treatment. 500mg Nigella Sativa oil (MARNYS Cuminmar) twice daily for 10 days. NCT04401202. | ||
Jul 27 2021 |
et al., International Journal of Nanomedicine, doi:10.2147/IJN.S314321 (Review) | Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review |
| Review of thymoquinone (a component of nigella sativa) research, antioxidant, anti-inflammatory, and antineoplastic properties, application to lung conditions, and the potential advantages of nanoformulations on drug solubility, cellular .. | ||
Jul 23 2021 |
et al., Vascular Pharmacology, doi:10.1016/j.vph.2021.106899 (Review) | The potential role of thymoquinone in preventing the cardiovascular complications of COVID-19 |
| Review of the potential role of thymoquinone (a component of nigella sativa) in minimizing cardiovascular complications of COVID-19. | ||
Jul 23 2021 |
et al., Clinical and Experimental Pharmacology and Physiology, doi:10.1111/1440-1681.13553 (Review) | The role of thymoquinone, a major constituent of Nigella sativa, in the treatment of inflammatory and infectious diseases |
| Review of the pharmacological properties of nigella sativa and thymoquinone and application for a variety of diseases, focusing on recent studies of the anti-inflammatory and antiviral properties that are promising for diseases including .. | ||
Jul 12 2021 |
et al., Indonesian Journal of Chemistry, doi:10.22146/ijc.65951 | Exploring the Potency of Nigella sativa Seed in Inhibiting SARS-CoV-2 Main Protease Using Molecular Docking and Molecular Dynamics Simulations |
| In Silico study showing nigella sativa metabolites binding to SARS-CoV-2 Mpro. | ||
May 11 2021 |
et al., International Journal of Environmental Research and Public Health, doi:10.3390/ijerph18105086 | Patients’ Behavior Regarding Dietary or Herbal Supplements before and during COVID-19 in Saudi Arabia |
| 24% lower hospitalization [p=0.09]. Retrospective survey-based analysis of 738 COVID-19 patients in Saudi Arabia, showing lower hospitalization with vitamin C, turmeric, zinc, and nigella sativa, and higher hospitalization with vitamin D. For vitamin D, most patients contin.. | ||
May 5 2021 |
et al., Research Square, doi:10.21203/rs.3.rs-26464/v1 (Preprint) | Active-site Molecular docking of Nigellidine to nucleocapsid/Nsp2/Nsp3/MPro of COVID-19 and to human IL1R and TNFR1/2 may stop viral-growth/cytokine-flood, and the drug source Nigella sativa (black cumin) seeds show potent antioxidant role in experimental rats |
| In Silico and animal study of nigella sativa and component nigellidine, showing nigellidine binding activity for several important SARS-CoV-2 proteins and for relevant host receptors; and that black cumin seed extract was antioxidative, h.. | ||
Mar 12 2021 |
et al., Bulletin of the National Research Centre, doi:10.1186/s42269-021-00517-x | In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets |
| In Silico study of compounds from Nigella Sativa oil. Authors identify component phytochemicals with gas chromatography-mass spectrometry and analyze binding affinity with SARS-CoV-2 targets. Caryophyllene oxide, α-bergamotene, and β-bisa.. | ||
Mar 4 2021 |
et al., Healthbook Times, doi:10.36000/hbT.2021.01.001 | Response to Nigella sativa in Patients with Confirmed and Suspected COVID-19 |
| Retrospective 35 patients treated with Nigella Sativa showing good outcomes and relatively fast recovery. There was no control group. | ||
Jan 31 2021 |
et al., Pakistan Journal of Medical and Health Sciences, 15:1 | Preventive Value of Black Seed in People at Risk of Infection with COVID-19 |
| 62% fewer symptomatic cases [p<0.0001]. Prophylaxis study with 376 mostly high-risk patients, 188 treated with nigella sativa, showing significantly lower cases with treatment. Black seeds 40mg/kg orally once daily. | ||
Jan 31 2021 |
et al., Indian Journal of Forensic Medicine & Toxicology, 15:3 (date from earlier preprint) | Clinical Trial of Black Seeds Against COVID – 19 in Kirkuk City / Iraq |
| 96% lower mortality [p=0.001] and 93% lower severe cases [p<0.0001]. Open-label RCT with 419 patients in Iraq, 160 treated with Nigella Sativa, showing lower mortality and severe cases with treatment. Black seeds 40mg/kg orally once daily for 14 days. | ||
Nov 3 2020 |
et al., Phytotherapy Research, doi:10.1002/ptr.7640 (date from earlier preprint) | Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multi-center placebo-controlled randomized clinical trial |
| 82% lower mortality [p=0.01], 84% improved recovery [p<0.0001], and 82% improved viral clearance [p<0.0001]. RCT with 157 patients treated with honey and nigella sativa, and 156 control patients, showing significantly faster recovery and viral clearance. Honey (1gm/kg/day) plus encapsulated nigella sativa seeds (80mg/kg/day) orally in 2-3 divide.. | ||
Oct 15 2020 |
et al., Am J Blood Res., doi: | Promising preventive and therapeutic effects of TaibUVID nutritional supplements for COVID-19 pandemic: towards better public prophylaxis and treatment (A retrospective study) |
| Small retrospective study of 20 patients in Egypt suggesting benefits of TaibUVID (nigella sativa, chamomile and honey) treatment. | ||
Jul 10 2020 |
et al., Phytomedicine, doi:10.1016/j.phymed.2020.153277 (Review) | Potential influence of Nagella sativa (Black cumin) in reinforcing immune system: A hope to decelerate the COVID-19 pandemic |
| Review of immune-regulating, anti-inflammatory, and antioxidant benefits of nigella sativa, and potential benefits for COVID-19. | ||
Jun 26 2020 |
et al., Phytotherapy Research, doi:10.1002/ptr.6793 (Review) (Preprint) | Covid-19 and thymoquinone: Connecting the dots |
| Review of the potential benefits of thymoquinone (a component of nigella sativa) for COVID-19, recommending clinical trials. | ||
Apr 2 2020 |
et al., ChemRxiv, doi:10.26434/chemrxiv.12055716.v1 (Preprint) | Identification of Compounds from Nigella Sativa as New Potential Inhibitors of 2019 Novel Coronasvirus (Covid-19): Molecular Docking Study |
| In Silico study of compounds from nigella sativa identifying nigellidine and α-Hederin as potential compounds that inhibit SARS-CoV-2. | ||
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.
Thanks for your feedback! Please search before submitting papers and note
that studies are listed under the date they were first available, which may be
the date of an earlier preprint.